Logo image of CPIX

CUMBERLAND PHARMACEUTICALS (CPIX) Stock Fundamental Analysis

NASDAQ:CPIX - Nasdaq - US2307701092 - Common Stock - Currency: USD

4.845  -0.33 (-6.47%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to CPIX. CPIX was compared to 198 industry peers in the Pharmaceuticals industry. Both the profitability and financial health of CPIX have multiple concerns. CPIX has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

CPIX had negative earnings in the past year.
In the past year CPIX has reported a negative cash flow from operations.
CPIX had negative earnings in each of the past 5 years.
Of the past 5 years CPIX 4 years had a positive operating cash flow.
CPIX Yearly Net Income VS EBIT VS OCF VS FCFCPIX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5M -5M -10M

1.2 Ratios

CPIX has a better Return On Assets (-8.57%) than 70.71% of its industry peers.
Looking at the Return On Equity, with a value of -28.35%, CPIX is in the better half of the industry, outperforming 64.14% of the companies in the same industry.
Industry RankSector Rank
ROA -8.57%
ROE -28.35%
ROIC N/A
ROA(3y)-7.42%
ROA(5y)-5.97%
ROE(3y)-21.64%
ROE(5y)-16.04%
ROIC(3y)N/A
ROIC(5y)N/A
CPIX Yearly ROA, ROE, ROICCPIX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5 -10 -15 -20 -25

1.3 Margins

CPIX's Gross Margin of 82.61% is amongst the best of the industry. CPIX outperforms 87.37% of its industry peers.
In the last couple of years the Gross Margin of CPIX has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for CPIX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 82.61%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.33%
GM growth 5Y1.04%
CPIX Yearly Profit, Operating, Gross MarginsCPIX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60 80

More info and screens

3

2. Health

2.1 Basic Checks

CPIX does not have a ROIC to compare to the WACC, probably because it is not profitable.
CPIX has less shares outstanding than it did 1 year ago.
CPIX has less shares outstanding than it did 5 years ago.
CPIX has a worse debt/assets ratio than last year.
CPIX Yearly Shares OutstandingCPIX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
CPIX Yearly Total Debt VS Total AssetsCPIX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

Based on the Altman-Z score of 0.68, we must say that CPIX is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of CPIX (0.68) is better than 60.10% of its industry peers.
CPIX has a Debt/Equity ratio of 0.45. This is a healthy value indicating a solid balance between debt and equity.
CPIX's Debt to Equity ratio of 0.45 is in line compared to the rest of the industry. CPIX outperforms 41.92% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF N/A
Altman-Z 0.68
ROIC/WACCN/A
WACC9.27%
CPIX Yearly LT Debt VS Equity VS FCFCPIX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

2.3 Liquidity

A Current Ratio of 1.15 indicates that CPIX should not have too much problems paying its short term obligations.
CPIX has a Current ratio of 1.15. This is amonst the worse of the industry: CPIX underperforms 80.30% of its industry peers.
A Quick Ratio of 1.03 indicates that CPIX should not have too much problems paying its short term obligations.
CPIX's Quick ratio of 1.03 is on the low side compared to the rest of the industry. CPIX is outperformed by 75.25% of its industry peers.
Industry RankSector Rank
Current Ratio 1.15
Quick Ratio 1.03
CPIX Yearly Current Assets VS Current LiabilitesCPIX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

More info and screens

1

3. Growth

3.1 Past

CPIX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -144.44%.
CPIX shows a decrease in Revenue. In the last year, the revenue decreased by -4.26%.
Measured over the past years, CPIX shows a small growth in Revenue. The Revenue has been growing by 1.95% on average per year.
EPS 1Y (TTM)-144.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%81.82%
Revenue 1Y (TTM)-4.26%
Revenue growth 3Y1.71%
Revenue growth 5Y1.95%
Sales Q2Q%11.66%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CPIX Yearly Revenue VS EstimatesCPIX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
CPIX Yearly EPS VS EstimatesCPIX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2018 2019 2020 2023 2024 0 0.2 -0.2

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CPIX. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CPIX Price Earnings VS Forward Price EarningsCPIX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CPIX Per share dataCPIX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2 2.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CPIX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CUMBERLAND PHARMACEUTICALS

NASDAQ:CPIX (4/24/2025, 8:01:13 PM)

4.845

-0.33 (-6.47%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)03-04 2025-03-04/amc
Earnings (Next)05-13 2025-05-13
Inst Owners22.01%
Inst Owner Change0%
Ins Owners3.59%
Ins Owner Change0%
Market Cap67.68M
Analysts43.33
Price TargetN/A
Short Float %4.05%
Short Ratio0.16
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.79
P/FCF N/A
P/OCF N/A
P/B 2.96
P/tB 17.07
EV/EBITDA N/A
EPS(TTM)-0.08
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)-0.04
OCFYN/A
SpS2.71
BVpS1.64
TBVpS0.28
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -8.57%
ROE -28.35%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 82.61%
FCFM N/A
ROA(3y)-7.42%
ROA(5y)-5.97%
ROE(3y)-21.64%
ROE(5y)-16.04%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.33%
GM growth 5Y1.04%
F-Score4
Asset Turnover0.5
Health
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 2.97%
Cap/Sales 0.47%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.15
Quick Ratio 1.03
Altman-Z 0.68
F-Score4
WACC9.27%
ROIC/WACCN/A
Cap/Depr(3y)16.58%
Cap/Depr(5y)20.37%
Cap/Sales(3y)2.19%
Cap/Sales(5y)2.64%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-144.44%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%81.82%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-4.26%
Revenue growth 3Y1.71%
Revenue growth 5Y1.95%
Sales Q2Q%11.66%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-3.57%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-114.04%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-110.05%
OCF growth 3YN/A
OCF growth 5YN/A